No abstract available
MeSH terms
-
Advisory Committees
-
Anti-Inflammatory Agents, Non-Steroidal / pharmacology*
-
Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
-
Cause of Death
-
Drug Approval*
-
Enzyme Inhibitors / pharmacology
-
Enzyme Inhibitors / therapeutic use
-
Humans
-
Idiopathic Pulmonary Fibrosis / drug therapy*
-
Idiopathic Pulmonary Fibrosis / mortality
-
Idiopathic Pulmonary Fibrosis / physiopathology
-
Indoles / pharmacology*
-
Indoles / therapeutic use
-
Pyridones / pharmacology*
-
Pyridones / therapeutic use
-
United States
-
United States Food and Drug Administration
-
Vital Capacity / drug effects*
Substances
-
Anti-Inflammatory Agents, Non-Steroidal
-
Enzyme Inhibitors
-
Indoles
-
Pyridones
-
pirfenidone
-
nintedanib